Search the Community
Showing results for tags 'desvelafaxine'.
University of British Columbia Pharmaceutical Sciences Student Journal, Volume 3, Issue 1, March 21 2016, pages 31-33. Preparation of Lower Dosages of SNRI Antidepressants to Ameliorate Discontinuation Symptoms: Two Case Studies. Benton Attfield, B.Sc. (Biology), B.Sc. (Pharm) Lori Bonertz, B.Sc. (Pharm) Cory Hermans, B.Sc. (Pharm) Valerie Kantz, Senior Pharmacy Technician. Full text pssj-v03-i01_attfield.pdf Abstract There is a large body of evidence showing that adverse effects experienced with antidepressant treatment ameliorate over time and that disease-state symptoms improve for many patients. However, there is a paucity of information relating to how to stop these medications when a patient’s depression has remitted. Presented here are two cases that demonstrate the role pharmacists play in helping patients discontinue SNRI medications through the preparation of lower strength dosage forms. From the paper: